Century Therapeutics (IPSC) Treasury Shares (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Treasury Shares of $7.2 million for Q1 2026, up 53.77% year-over-year from $4.7 million in Q1 2025, and up 27.37% quarter-over-quarter from $5.6 million in Q4 2025.
Century Therapeutics (IPSC) Treasury Shares (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Treasury Shares for 7 consecutive years, with $7.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 53.77% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (up 53.77% YoY), while the FY2025 annual figure was $5.6 million, up 97.9% from the prior year.
- Treasury Shares rose to $7.2 million in Q1 2026 per IPSC's latest filing, from $5.6 million in the prior quarter.
- Across five years, Treasury Shares topped out at $58.5 million in Q4 2022 and bottomed at $24821.0 in Q4 2024.
- Historically, Treasury Shares has averaged $5.9 million across 5 years, with a median of $3.9 million in 2024.
- Annual changes were most pronounced in 2023 — Treasury Shares sank 99.92% — and 2025, when it surged 22646.69%.
- Century Therapeutics' Treasury Shares stood at $58.5 million in 2022, then tumbled by 99.92% to $49416.0 in 2023, then tumbled by 49.77% to $24821.0 in 2024, then soared by 22646.69% to $5.6 million in 2025, then climbed by 27.37% to $7.2 million in 2026.
- Business Quant data shows IPSC's Treasury Shares at $7.2 million in Q1 2026, $5.6 million in Q4 2025, and $6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.05 Mn |
| Jun 30, 2026 | 7.05 Mn |
| Mar 31, 2026 | 7.19 Mn |
| Mar 31, 2026 | 7.19 Mn |
| Dec 31, 2025 | 5.65 Mn |
| Dec 31, 2025 | 5.65 Mn |
| Sep 30, 2025 | 6.63 Mn |
| Sep 30, 2025 | 6.63 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Mar 31, 2025 | 4.68 Mn |
| Mar 31, 2025 | 4.68 Mn |
| Dec 31, 2024 | 24,821.00 |
| Dec 31, 2024 | 24,821.00 |
| Sep 30, 2024 | 4.11 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 4.11 Mn |
| Mar 31, 2024 | 3.94 Mn |
| Mar 31, 2024 | 3.94 Mn |